Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

476.42
-0.01000.00%
Post-market: 490.0013.58+2.85%17:32 EDT
Volume:4.02M
Turnover:1.91B
Market Cap:23.61B
PE:45.29
High:481.17
Open:477.43
Low:465.02
Close:476.43
52wk High:625.99
52wk Low:228.00
Shares:49.56M
Float Shares:48.15M
Volume Ratio:6.82
T/O Rate:8.35%
Dividend:0.80
Dividend Rate:0.17%
EPS(TTM):10.52
EPS(LYR):10.52
ROE:25.75%
ROA:11.87%
PB:10.60
PE(LYR):45.29

Loading ...

Carpenter Technology Corp - Appoints Tony Thene as Chief Executive Officer Effective Immediately

THOMSON REUTERS
·
Jul 27

Press Release: Carpenter Technology Announces the Passing of Brian Malloy

Dow Jones
·
Jul 27

Earning Preview: Carpenter Technology revenue expected to increase by 8.93%, institutions lean bullish on margin expansion

Earnings Agent
·
Jul 24

Prominent Platform Company Ordered to Pay 547.9 Million Yuan in Back Taxes for Cross-Border Tax Evasion

Deep News
·
Jul 22

Billionaires are Loading up on These Superior Stocks. Why it Pays to Follow Their Money.

Dow Jones
·
Jul 18

JPMorgan ups Carpenter target, places on ‘Negative Catalyst Watch’

TIPRANKS
·
Jul 14

U.S. Research Roundup: Airbnb, Doordash, Zillow Group

Reuters
·
Jul 14

Billionaires are Loading up on These Superior Stocks. Why it Pays to Follow Their Money.

Dow Jones
·
Jul 14

J.P. Morgan Remains a Buy on Carpenter Technology (CRS)

TIPRANKS
·
Jul 13

Poolbeg Pharma Begins POLB 001 Trial, Targets Major CRS Market Opportunity

TIPRANKS
·
Jul 13

Is Carpenter Technology (CRS) Fully Valued Following Its Russell Index Removals?

Simply Wall St.
·
Jul 10

Carpenter Tech is Maintained at Positive by Susquehanna

Dow Jones
·
Jul 10

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

GlobeNewswire
·
Jul 07

Carpenter Technology Announces Conference Call and Webcast

GlobeNewswire
·
Jul 01

Carpenter Tech is Maintained at Overweight by Keybanc

Dow Jones
·
Jun 30

Analysts’ Top Industrial Goods Picks: Carpenter Technology (CRS), AeroVironment (AVAV)

TIPRANKS
·
Jun 30

Leads Biolabs Announces Partner Oblenio Bio’s $62 Million Oversubscribed Series B Financing to Advance Tri-Specific T-Cell Engager LBL‑051 for Autoimmune Diseases into Clinical Development

GlobeNewswire
·
Jun 25

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

GlobeNewswire
·
Jun 14

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

GlobeNewswire
·
Jun 14

Movement Alert|Carpenter Technology Rises 5.01% in Regular Trading, Trading at $548.98

Market Focus
·
Jun 11